NCT04763876View on ClinicalTrials.gov

Intramuscular Ketorolac at Two Single-Dose Regimens

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 27, 2020

Primary Completion Date

November 9, 2020

Study Completion Date

February 4, 2021

Conditions
Musculoskeletal PainAnalgesiaAdverse Event
Interventions
DRUG

Ketorolac Injection 15 mg

A single dose of 15 mg ketorolac administered intramuscularly.

DRUG

Ketorolac Injection 60 mg

A single dose of 60 mg ketorolac administered intramuscularly.

Trial Locations (1)

79920

William Beaumont Army Medical Center, El Paso

All Listed Sponsors
lead

William Beaumont Army Medical Center

FED

NCT04763876 - Intramuscular Ketorolac at Two Single-Dose Regimens | Biotech Hunter | Biotech Hunter